Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $4.42 and traded as high as $4.47. Evotec shares last traded at $4.42, with a volume of 44,607 shares traded.
Evotec Trading Down 4.5 %
The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The firm has a market cap of $1.46 billion, a P/E ratio of 10.78 and a beta of 0.98. The firm’s 50-day simple moving average is $4.42 and its 200 day simple moving average is $4.16.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Read More
- Five stocks we like better than Evotec
- Differences Between Momentum Investing and Long Term Investing
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Canadian Penny Stocks: Can They Make You Rich?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- What is a buyback in stocks? A comprehensive guide for investors
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.